Free Trial

Totally (TLY) Competitors

Totally logo
GBX 0.30 -1.13 (-78.95%)
As of 05/23/2025 12:30 PM Eastern

TLY vs. KNB, SPI, MGP, SBI, CHLL, IXI, PRM, MXC, AVO, and INHC

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Chill Brands Group (CHLL), IXICO (IXI), Proteome Sciences (PRM), Argent BioPharma (MXC), Advanced Oncotherapy (AVO), and Induction Healthcare Group (INHC). These companies are all part of the "medical" sector.

Totally vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
131
72.38%
Underperform Votes
50
27.62%

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.29-0.17
Totally£133.05M0.00-£3.79M-£1.93-0.16

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 51.3% of Totally shares are held by institutional investors. 37.0% of Kanabo Group shares are held by company insiders. Comparatively, 13.3% of Totally shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-717.63% -121.77% -20.89%
Totally -2.85%-11.01%-2.42%

Totally has a consensus price target of GBX 20, suggesting a potential upside of 6,566.67%. Given Totally's stronger consensus rating and higher probable upside, analysts plainly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

In the previous week, Totally had 5 more articles in the media than Kanabo Group. MarketBeat recorded 5 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 0.15 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the news media.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

Summary

Totally beats Kanabo Group on 13 of the 17 factors compared between the two stocks.

Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£590,000.00£1.63B£5.34B£2.66B
Dividend Yield13.16%3.83%5.27%4.79%
P/E Ratio-0.167.1726.96135.59
Price / Sales0.0012.65398.82224,602.93
Price / Cash9.0812.5138.3228.30
Price / Book0.021.956.773.89
Net Income-£3.79M£58.65M£3.24B£5.94B
7 Day Performance-78.60%0.88%0.27%3.64%
1 Month Performance-92.57%152.04%5.91%24.61%
1 Year Performance-95.56%10.25%18.83%29.34%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
2.92 of 5 stars
GBX 0.30
-78.9%
GBX 20
+6,566.7%
-95.6%£590,000.00£133.05M-0.161,668News Coverage
Gap Down
High Trading Volume
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14M-0.1720
SPI
Spire Healthcare Group
1.8513 of 5 stars
GBX 193.40
-1.9%
GBX 300
+55.1%
-25.0%£776.64M£1.44B27.53420News Coverage
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007
IXI
IXICO
N/AGBX 11.25
-7.8%
N/A+57.9%£10.43M£11.50M-2.9289Earnings Report
PRM
Proteome Sciences
N/AGBX 3.33
-16.9%
N/A-10.8%£9.81M£10.88B-2.41240Gap Down
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
INHC
Induction Healthcare Group
N/AGBX 10
+5.3%
N/A-23.2%£9.23M£12.57M-1.8074Gap Down

Related Companies and Tools


This page (LON:TLY) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners